Multifocal brain damage induced by phencyclidine is augmented by pilocarpine

Area of Science:

• Neuroscience
• Neuropharmacology
• Histopathology

Background:

• Phencyclidine (PCP) and other N-methyl-D-aspartate (NMDA) receptor antagonists induce psychosis in humans.
• Low-dose PCP causes reversible neurotoxicity in rat retrosplenial granular cortex.
• Higher or prolonged PCP doses may cause disseminated brain damage, but its reversibility and reproducibility are unclear.

Purpose of the Study:

• To investigate the reversibility, reproducibility, and extent of phencyclidine-induced neurotoxicity in the rat brain.
• To identify the specific neuronal populations at risk from phencyclidine exposure.
• To explore the effect of pilocarpine augmentation on phencyclidine neurotoxicity patterns.

Main Methods:

• Utilized multiple histological techniques: plastic-embedded thin sections (light and electron microscopy), H&E staining, 72 kDa heat shock protein immunocytochemistry, and de Olmos silver impregnation.
• Examined lesions in rat brains after phencyclidine administration, alone and combined with pilocarpine.

Main Results:

• Phencyclidine can induce neuronal death across widespread cerebrocortical and limbic regions.
• The multifocal pattern of damage occurred inconsistently in a small percentage of rats treated with phencyclidine alone.
• Combining phencyclidine with a low dose of pilocarpine significantly increased the consistency of widespread brain damage.

Conclusions:

• Phencyclidine can cause extensive neuronal degeneration in the rat brain.
• Pilocarpine co-administration enhances the reproducibility of phencyclidine-induced widespread neurotoxicity.
• Disinhibition of converging excitatory pathways is the proposed mechanism for phencyclidine-triggered neurodegeneration.